Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by selective neuronal loss, amyloid plaques and neurofibrillary tangles. Oxidative stress may play an important role in the pathogenesis of AD which is associated with the accumulation of β-amyloid (Aβ). Jatrorrhizine (JAT) is a novel tetrahydroisoquinoline alkaloid originally extracted from the Chinese herb coptidis rhizome. Our previous studies showed that JAT protected neuronallike cells against H2O2 -induced toxicity. In this study, we investigated the protective effects of JAT against Aβ25-35- induced cell death in rat cortical neurons. When the cortical neurons were exposed to 25μM Aβ25-35 for 24h, there was a significant reduction in cell viability and activities of SOD and GSH-Px. It also increased the production of malondialdehyde (MDA) and ROS but reduced MMP. Pretreatment of the cortical neurons with various concentrations of JAT (1-10μM) attenuated Aβ25-35-induced neurotoxicity markedly. JAT was also showed to suppress the activation of caspase-3 induced by Aβ25-35 and prevented the cytochrome c transporting into the cytosol. These results indicate that JAT demonstrates the neuroprotective effects against Aβ25-35-induced injury via its antioxidative potential, which may provide a therapeutical potential to AD.
Keywords: β-amyloid (25-35), JAT, Alzheimer’s disease, oxidative stress, apoptosis, antioxidative potential, malondialdehyde, neurofibrillary tangles, neurotoxicity, cortical neurons.
CNS & Neurological Disorders - Drug Targets
Title:The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
Volume: 11 Issue: 8
Author(s): Tao Luo, Wei Jiang, Yan Kong, Sheng Li, Feng He, Jie Xu and Hua-Qiao Wang
Affiliation:
Keywords: β-amyloid (25-35), JAT, Alzheimer’s disease, oxidative stress, apoptosis, antioxidative potential, malondialdehyde, neurofibrillary tangles, neurotoxicity, cortical neurons.
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by selective neuronal loss, amyloid plaques and neurofibrillary tangles. Oxidative stress may play an important role in the pathogenesis of AD which is associated with the accumulation of β-amyloid (Aβ). Jatrorrhizine (JAT) is a novel tetrahydroisoquinoline alkaloid originally extracted from the Chinese herb coptidis rhizome. Our previous studies showed that JAT protected neuronallike cells against H2O2 -induced toxicity. In this study, we investigated the protective effects of JAT against Aβ25-35- induced cell death in rat cortical neurons. When the cortical neurons were exposed to 25μM Aβ25-35 for 24h, there was a significant reduction in cell viability and activities of SOD and GSH-Px. It also increased the production of malondialdehyde (MDA) and ROS but reduced MMP. Pretreatment of the cortical neurons with various concentrations of JAT (1-10μM) attenuated Aβ25-35-induced neurotoxicity markedly. JAT was also showed to suppress the activation of caspase-3 induced by Aβ25-35 and prevented the cytochrome c transporting into the cytosol. These results indicate that JAT demonstrates the neuroprotective effects against Aβ25-35-induced injury via its antioxidative potential, which may provide a therapeutical potential to AD.
Export Options
About this article
Cite this article as:
Luo Tao, Jiang Wei, Kong Yan, Li Sheng, He Feng, Xu Jie and Wang Hua-Qiao, The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080013
DOI https://dx.doi.org/10.2174/1871527311211080013 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Heart and Brain Axis Targets in CNS Neurological Disorders
Recently there has been a surge of interest in delving deeper into the complex interplay between the heart and brain. This fascination stems from a growing recognition of the profound influence each organ holds over the other, particularly in the realm of central nervous system (CNS) neurological disorders. The purpose ...read more
Lifestyle Interventions to Prevent and Treat Cognitive Impairment and Dementia
More than 55 million people live with dementia worldwide. By 2050, the population affected by dementia will exceed 139 million individuals. Mild cognitive impairment (MCI) is a pre-dementia stage, also known as prodromal dementia, affecting older adults. MCI emerges years before the manifestation of dementia but can be avoidable and ...read more
Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities
The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more
Role of glial cells in autism spectrum disorder: Molecular mechanism and therapeutic approaches
Emerging evidence suggests that glial cells may play a pivotal role in neuroanatomical and behavioral changes found in autism spectrum disorder (ASD). Many individuals with ASD experience a neuro-immune system abnormalities throughout life, which implicates a potential role of microglia in the pathogenesis of ASD. Dysfunctional astrocytes and oligodendrocytes were ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research Antioxidant Activity of Galantamine and Some of its Derivatives
Current Medicinal Chemistry Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders
Current Molecular Medicine Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives
CNS & Neurological Disorders - Drug Targets Adenosine-to-Inosine RNA Editing: Perspectives and Predictions
Mini-Reviews in Medicinal Chemistry Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer’s Disease
Current Topics in Medicinal Chemistry Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy
CNS & Neurological Disorders - Drug Targets Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects
Current Alzheimer Research An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Intrahippocampal Amyloid-β (1-40) Injections Injure Medial Septal Neurons in Rats
Current Alzheimer Research Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions
Mini-Reviews in Medicinal Chemistry Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design
Current Pharmaceutical Design Synthesis and in vitro Antitumor Effect of New Vindoline Derivatives Coupled with Triphenylphosphine
Current Organic Chemistry Deciphering the Role of Nanoparticle-based Treatment for Parkinson’s Disease
Current Drug Metabolism Genetics and Therapies for GM2 Gangliosidosis
Current Gene Therapy Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy Acting Before; A Combined Strategy to Counteract the Onset and Progression of Dementia
Current Alzheimer Research